These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15660891)

  • 1. Cutaneous tumors as the initial presentation of non-T, non-B, nonmyeloid CD4+ CD56+ hematolymphoid malignancy in an adolescent boy.
    Fass J; Tichy EH; Kraus EW; Herrick JL; Ehsan A; Peterson J; Grimwood RE
    Pediatr Dermatol; 2005; 22(1):19-22. PubMed ID: 15660891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin manifestations in CD4+, CD56+ malignancies.
    Penven K; Macro M; Salaun V; Comoz F; Reman O; Leroy D; Troussard X; Petrella T; Dompmartin A
    Eur J Dermatol; 2003; 13(2):161-5. PubMed ID: 12695132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+/CD56+ haematodermic neoplasm: a preculsor haematological neoplasm that frequently first presents in the skin.
    Martín JM; Nicolau MJ; Galán A; Ferrández-Izquierdo A; Ferrer AM; Jordá E
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1129-32. PubMed ID: 16987271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
    Patel JL; Shetty S; Salama ME
    Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD2- CD4+ CD56+ hematodermic/hematolymphoid malignancy.
    Kato N; Yasukawa K; Kimura K; Sugawara H; Aoyagi S; Mishina T; Nakata T
    J Am Acad Dermatol; 2001 Feb; 44(2):231-8. PubMed ID: 11174380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ CD56+ hematodermic neoplasm.
    Cibull TL; Thomas AB; O'Malley DP; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):59-61. PubMed ID: 17284963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm).
    Su O; Onsun N; Demirkesen C; Aydin Y; Pirmit S; Gereli M
    Dermatol Online J; 2010 Apr; 16(4):8. PubMed ID: 20409415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+, CD56+ mycosis fungoides: case report and review of the literature.
    Horst BA; Kasper R; LeBoit PE
    Am J Dermatopathol; 2009 Feb; 31(1):74-6. PubMed ID: 19155730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature.
    Campbell SM; Moad JC; Sammons DL; Zirwas M
    Cutis; 2012 Jun; 89(6):278-83. PubMed ID: 22838092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
    Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH
    Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
    Ascani S; Massone C; Ferrara G; Rongioletti F; Papini M; Pileri S; Cerroni L
    J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M; García-Arpa M; González-García J
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
    Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
    Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
    Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
    J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge.
    Ferran M; Gallardo F; Ferrer AM; Salar A; Pérez-Vila E; Juanpere N; Salgado R; Espinet B; Orfao A; Florensa L; Pujol RM
    Br J Dermatol; 2008 May; 158(5):1129-33. PubMed ID: 18294313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
    Ruggiero A; Maurizi P; Larocca LM; Arlotta A; Riccardi R
    Haematologica; 2006 Dec; 91(12 Suppl):ECR48. PubMed ID: 17194654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha).
    Piña-Oviedo S; Herrera-Medina H; Coronado H; Del Valle L; Ortiz-Hidalgo C
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):481-6. PubMed ID: 18091395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
    Petrella T; Bagot M; Willemze R; Beylot-Barry M; Vergier B; Delaunay M; Meijer CJ; Courville P; Joly P; Grange F; De Muret A; Machet L; Dompmartin A; Bosq J; Durlach A; Bernard P; Dalac S; Dechelotte P; D'Incan M; Wechsler J; Teitell MA
    Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M; Jones D
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroa-like lymphoma with CD56 expression.
    Doeden K; Molina-Kirsch H; Perez E; Warnke R; Sundram U
    J Cutan Pathol; 2008 May; 35(5):488-94. PubMed ID: 17976208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.